This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Eastman (EMN), Patagonia Unite to Tackle Global Textile Waste
by Zacks Equity Research
Eastman (EMN) collaborates with Patagonia to recycle 8,000 pounds of pre- and post-consumer garment waste.
Eastman Chemical (EMN) Shares Rally 18% in 6 Months: Here's Why
by Zacks Equity Research
Eastman Chemical (EMN) gains on cost-management actions and innovation and maintains a disciplined approach to capital allocation.
Why Is DuPont de Nemours (DD) Up 5.7% Since Last Earnings Report?
by Zacks Equity Research
DuPont de Nemours (DD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Air Products and Chemicals (APD) Up 9.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Air Products and Chemicals (APD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why You Should Retain Eastman Chemical (EMN) in Your Portfolio
by Zacks Equity Research
While Eastman Chemical (EMN) faces headwinds from weak demand and inventory de-stocking, it benefits from productivity actions and innovation.
Eastman (EMN) Partners Nord Pal Plast for Feedstock in France
by Zacks Equity Research
Eastman's (EMN) molecular recycling technologies enable the breakdown of hard-to-recycle waste into molecular building blocks.
Eastman (EMN), Rumpke Tie Up to Expand PET Waste Recycling
by Zacks Equity Research
Eastman (EMN) will employ its molecular recycling technology to convert the waste stream into virgin quality polyesters.
Zacks Industry Outlook Highlights Air Products and Chemicals, Dow and Eastman Chemical
by Zacks Equity Research
Air Products and Chemicals, Dow and Eastman Chemical have been highlighted in this Industry Outlook article.
3 Diversified Chemical Stocks to Watch Amid Demand Woes
by Anindya Barman
Demand softness in specific markets, de-stocking and the slowdown in China and Europe pose headwinds for the Zacks Chemicals Diversified industry. APD, DOW and EMN are poised to navigate the industry challenges.
Eastman's (EMN) Earnings and Sales Surpass Estimates in Q4
by Zacks Equity Research
The top line of Eastman's (EMN) is hurt by lower sales volumes and selling prices in Q4.
Eastman Chemical (EMN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Eastman Chemical (EMN) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Eastman Chemical (EMN) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Eastman Chemical (EMN) delivered earnings and revenue surprises of 2.34% and 1.86%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Eastman (EMN) and Swiss Eyewear to Launch INVU Collection
by Zacks Equity Research
SEG selects Eastman (EMN)Tritan Renew because it is a one-of-a-kind material that combines remarkable, environmentally friendly properties without imposing manufacturing limits.
Unlocking Q4 Potential of Eastman Chemical (EMN): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Eastman Chemical (EMN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.
Eastman Chemical (EMN) to Post Q4 Earnings: Factors at Play
by Zacks Equity Research
Eastman (EMN) is expected to have benefited from cost-cutting and productivity initiatives as well as its innovation initiatives amid demand headwinds in Q4.
Eastman Chemical (EMN) Gains on Cost Cuts and Innovation
by Zacks Equity Research
Eastman Chemical (EMN) benefits from cost-management actions and innovation amid challenges from soft demand and consumer de-stocking in certain markets.
LyondellBasell (LYB) Reports Next Week: What to Expect
by Zacks Equity Research
LyondellBasell (LYB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Eastman Chemical (EMN) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Eastman Chemical (EMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Eastman Chemical (EMN) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Eastman Chemical (EMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Eastman Chemical (EMN) Shares Pop 17% in 3 Months: Here's Why
by Zacks Equity Research
Eastman Chemical (EMN) gains on cost-management actions and innovation and maintains a disciplined approach to capital allocation.
Should Value Investors Buy Eastman Chemical (EMN) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured highlights include GigaCloud Technology, SkyWest, Ramaco Resources, Eastman Chemical and Catalyst Pharmaceuticals
by Zacks Equity Research
GigaCloud Technology, SkyWest, Ramaco Resources, Eastman Chemical and Catalyst Pharmaceuticals are part of the Screen of the Week article.
5 Value Stocks With Strong Earnings Yield to Rev Up Returns
by Rimmi Singhi
Consider investing in high-yield value stocks like GCT, SKYW, METC, EMN and CPRX to unlock your portfolio's potential.
Is Arkema (ARKAY) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why You Should Buy Eastman Chemical (EMN) Stock Right Now
by Zacks Equity Research
Eastman Chemical (EMN) benefits from cost-management actions, operational execution and innovation.